The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Allay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational ...

From soothing toothaches to calming migraines, discover how everyday kitchen ingredients are proving more effective than ...

On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management an ...

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ...

Additionally, the development of combination drugs that incorporate multiple analgesics into a single dose has enhanced pain relief outcomes by targeting different pain pathways simultaneously.

Blue Scorpion Pain & Inflammation Relief is a groundbreaking homeopathic ... Renowned for its anti-inflammatory and analgesic properties, this ingredient is known to relieve swelling from insect ...

Providing pain relief during surgical animal husbandry procedures is a better choice for your livestock, your business and ...

The "Analgesics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...